{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:46:18Z","timestamp":1786635978943,"version":"build-2736575974"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Crit Illn Inj Sci"],"published-print":{"date-parts":[[2011]]},"DOI":"10.4103\/2229-5151.79277","type":"journal-article","created":{"date-parts":[[2011,4,12]],"date-time":"2011-04-12T06:31:46Z","timestamp":1302589906000},"page":"17","source":"Crossref","is-referenced-by-count":14,"title":["Risk factors for aminoglycoside-associated nephrotoxicity in surgical intensive care unit patients"],"prefix":"10.4103","volume":"1","author":[{"given":"AnthonyT","family":"Gerlach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"StanislawP","family":"Stawicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CharlesH","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/2229-5151.79277-1","doi-asserted-by":"crossref","unstructured":"The 10 x \u203220 Initiative: Pursuing a global commitment to develop 10 new antibacterial drugs by 2020. Clin Infect Dis 2010;50:1081-3.","DOI":"10.1086\/652237"},{"key":"key-10.4103\/2229-5151.79277-2","first-page":"1","volume-title":"Bad bugs, no drugs: No ESKAPE! An update from the Infectious Diseases Society of America","author":"Boucher","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/2229-5151.79277-3","first-page":"1079","volume-title":"Federal funding for the study of antimicrobial resistance in nosocomial pathogens: No ESKAPE","author":"Rice","year":"2008","journal-title":"J Infect Dis"},{"key":"key-10.4103\/2229-5151.79277-4","first-page":"462","volume-title":"Inadequate antimicrobial treatment of infections: A risk factor for hospital mortality among critically ill patients","author":"Kollef","year":"1999","journal-title":"Chest"},{"key":"key-10.4103\/2229-5151.79277-5","first-page":"26","volume-title":"Predictors of hospital mortality for patients with severe sepsis treated with Drotrecogin alfa (activated)","author":"Micek","year":"2005","journal-title":"Pharmacotherapy"},{"key":"key-10.4103\/2229-5151.79277-6","first-page":"412","volume-title":"The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit","author":"Zaragoza","year":"2003","journal-title":"Clin Microbiol Infect"},{"key":"key-10.4103\/2229-5151.79277-7","doi-asserted-by":"crossref","unstructured":"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:388-416.","DOI":"10.1164\/rccm.200405-644ST"},{"key":"key-10.4103\/2229-5151.79277-8","first-page":"296","volume-title":"Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008","author":"Dellinger","year":"2008","journal-title":"Crit Care Med"},{"key":"key-10.4103\/2229-5151.79277-9","first-page":"159","volume-title":"Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship","author":"Dellit","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/2229-5151.79277-10","first-page":"592","volume-title":"Old antibiotics for infections in critically ill patients","author":"Falagas","year":"2007","journal-title":"Curr Opin Crit Care"},{"key":"key-10.4103\/2229-5151.79277-11","first-page":"53","volume-title":"Revisiting the loading dose of amikacin for patients with severe sepsis and septic shock","author":"Taccone","year":"2010","journal-title":"Crit Care"},{"key":"key-10.4103\/2229-5151.79277-12","first-page":"2750","volume-title":"Aminoglycoside use in intensive care units and aminoglycoside nephrotoxicity.Comment letter 1","author":"Pogue","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/2229-5151.79277-13","first-page":"509","volume-title":"Survey of surgical infections currently known (SOSICK): A multicenter examination of antimicrobial use from the surgical infection society scientific studies committee","author":"Namias","year":"2008","journal-title":"Surg Infect (Larchmt)"},{"key":"key-10.4103\/2229-5151.79277-14","first-page":"2887","volume-title":"Prevalence and risk factors for aminoglycoside nephrotoxicity in intensive care units","author":"Oliveira","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/2229-5151.79277-15","first-page":"16S","volume-title":"Aminoglycoside nephrotoxicity","author":"Appel","year":"1990","journal-title":"Am J Med"},{"key":"key-10.4103\/2229-5151.79277-16","first-page":"173","volume-title":"Booker LA, Franck PA, Jenkins PL, Franck KR, Nafziger AN.Incidence of and significant risk factors for aminoglycoside-associated nephrotoxicity in patients dosed by using individualized pharmacokinetic monitoring","author":"Bertino","year":"1993","journal-title":"J Infect Dis"},{"key":"key-10.4103\/2229-5151.79277-17","first-page":"93","volume-title":"Modification of diet in renal disease, modified Cockcroft-Gault and 24-urine formulas are poor predictors of aminoglycosides in critically ill surgical patients","author":"Gerlach","year":"2009","journal-title":"Pharmacotherapy [Abstracr]"},{"key":"key-10.4103\/2229-5151.79277-18","first-page":"325","volume-title":"Vancomycin therapeutic guidelines: A summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists","author":"Rybak","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/2229-5151.79277-19","first-page":"1128","volume-title":"An Official ATS\/ERS\/ESICM\/SCCM\/SRLF Statement: Prevention and Management of Acute Renal Failure in the ICU Patient: An international consensus conference in intensive care medicine","author":"Brochard","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.4103\/2229-5151.79277-20","first-page":"1569","volume-title":"A comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patients","author":"Bagshaw","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/2229-5151.79277-21","first-page":"721","volume-title":"Clinical and pharmacokinetic characteristics of aminoglycoside nephrotoxicity in 201 critically ill patients","author":"Schentag","year":"1982","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/2229-5151.79277-22","first-page":"F907","volume-title":"Mechanism of ischemia-enhanced aminoglycoside binding and uptake by proximal tubule cells","author":"Molitoris","year":"1993","journal-title":"Am J Physiol"},{"key":"key-10.4103\/2229-5151.79277-23","first-page":"20","volume-title":"Gentamicin effects on renal ischemia\/reperfusion injury","author":"Zager","year":"1992","journal-title":"Circ Res"},{"key":"key-10.4103\/2229-5151.79277-24","first-page":"1205","volume-title":"Prediction of glomerular filtration rate using aminoglycoside clearance in critically ill medical patients","author":"Zarowitz","year":"1992","journal-title":"Ann Pharmacother"},{"key":"key-10.4103\/2229-5151.79277-25","first-page":"1487","volume-title":"Predictability of creatinine clearance estimates in critically ill patients","author":"Robert","year":"1993","journal-title":"Crit Care Med"}],"container-title":["International Journal of Critical Illness and Injury Science"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:52:26Z","timestamp":1786632746000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/2229-5151.79277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"alternative-id":["79277"],"URL":"https:\/\/doi.org\/10.4103\/2229-5151.79277","relation":{},"ISSN":["2229-5151"],"issn-type":[{"value":"2229-5151","type":"print"}],"subject":[],"published":{"date-parts":[[2011]]}}}